Recently, TrialSite reported on what is essentially an Australian miracle to date as the country has had limited impact from the COVID-19 pandemic for many months while little of the population has received any vaccination. Alternative media sites showcasing a resistance of the population to receive a COVID-19 jab were reviewed and verified. Significant numbers of people living there seem hesitant about receiving a COVID-19 vaccination. That hasn’t stopped the Australian government from making a deal with Moderna to procure 25 million doses of the Moderna mRNA-based vaccine. This includes 10 million doses of the vaccine against the ancestral strain (mRNA-1273) to be delivered in 2021 and 15 million doses of Moderna’s updated variant booster vaccine candidate to be delivered in 2022.
Subject to Regulatory Approvals
As Moderna recently disclosed in a press release, this latest purchase announcement is subject to regulatory approval of mRNA-1273 and booster vaccine candidates by the Therapeutic Goods Administration (TGA) of Australia. The Company expects to submit an application to the TGA shortly. As Moderna has continued to scale its commercial network, the Company announced...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).